Evaluating the role of Cardiac Genetics Nurses in inherited cardiac conditions services using a Maturity Matrix by Tonkin, Emma et al.
 EUROPEAN
SOCIETY OF
CARDIOLOGY ®
Introduction
Cardiovascular disease is a leading cause of death world-
wide and whilst genomic technologies are elucidating the 
role that genetic variants play in nearly all such diseases,1 
including common conditions such as coronary artery dis-
ease,2 the individual effect on risk of most variants is mod-
est. However, the monogenic inherited cardiovascular 
conditions (ICCs) are associated with much greater risk. 
There are over 50 of these, the four main categories com-
prising the cardiomyopathies, arrhythmia syndromes, for 
example, Long QT, inherited arteriopathies such as Marfan 
syndrome and muscular dystrophies.3 Collectively they 
represent a substantial burden of disease, with a prevalence 
in the United Kingdom (UK) estimated to be around 
340,000.3
For some ICCs, the first indication of disease is sudden 
cardiac death. Most of these conditions are associated with 
dominant inheritance, with a 50% risk to first-degree rela-
tives.4 Cascade screening plays a vital role in identifying 
such individuals via cardiac tests such as electrocardiogra-
phy and by DNA testing.5 Healthy individuals whose DNA 
test is mutation negative can be excluded from further fol-
low-up. High success rates in identifying affected family 
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members demonstrate the importance of this approach in 
initiating appropriate prophylaxis to ameliorate risk.6-8 
Cascade screening for conditions such as hypertrophic car-
diomyopathy and familial hypercholesterolaemia has been 
shown to be acceptable and cost-effective.9-12
Effective service provision is crucial for identifying and 
managing families affected by ICCs. The expertise of 
genetics services in routinely investigating family units and 
the potential complexity of clinical and genetic findings 
requires a multidisciplinary approach.13 With sudden car-
diac death, the UK National Health Service (NHS) is 
required to make provision for identifying family members 
at risk, providing ‘personally tailored, sensitive and expert 
support, diagnosis, treatment, information and advice to 
close relatives’.14 A comprehensive review of NHS ICC 
services identified 20 specialist services, most offering a 
variety of joint specialist clinics but with variable provision 
across all measures of activity surveyed, including range of 
specialist roles, number and range of outpatient clinics and 
new patients seen. The balance between cardiology and 
genetics consultant sessions also varied, with most ICC ser-
vices tending to be dominated by one specialty or the other, 
rather than an integrated service.3 Whilst most covered the 
four main ICC categories, significant inequities were noted 
and capacity to meet either current or future estimated 
needs deemed inadequate, with a 3–4-fold increase in 
regional provision for new patients needed to meet the 
shortfall.3
The survey noted the valuable role that Cardiac Genetics 
Nurses (CGNs) can play within the multidisciplinary ICC 
team, although only 10 services employed them. Such 
nurses can act as a bridge between cardiology and genetics 
specialist services, serving as the identified contact for the 
family, providing information and support, organising tests 
and contributing to clinical care.3
The British Heart Foundation (BHF), a UK charitable 
organisation, funded two CGN posts in 2006. Following 
the success of these, in 2008, after competitive tender, they 
funded nine ICC services, each to appoint a full-time CGN 
for three years, to help develop new service initiatives or to 
develop existing services further. The aim was to improve 
the quality of provision to patients and families through 
improving access, support and communication with and 
between cardiac and genetics services. The authors were 
commissioned to conduct an independent evaluation of the 
contribution of the new CGN posts to the ICC services 
where they were based. In this paper we report the creation 
and application of a framework to assess progress in ser-
vice development over time following their appointment.
Methods
The authors adopted a case study approach for the wider 
evaluation, treating CGNs as a single case, guided by an 
independent advisory group of medical consultants and 
nurses from cardiology and genetics, along with health 
policy, education and patient representatives. For this study, 
we needed to ascertain:
•	 What does an effective and sustainable ICC service 
look like?
•	 To what extent are its features achieved over time?
One challenge in measuring impact was the absence of 
nationally agreed ICC service benchmarks. A two-stage 
approach was taken to develop and apply an ICC Maturity 
Matrix as a framework to assess service development fol-
lowing the CGN appointments.
The CGNs were appointed between October 2008 and 
March 2009 across England (n=8) and Wales (n=1), work-
ing in multidisciplinary teams, each with a medical consult-
ant lead in genetics and/or cardiology. As experienced 
cardiac nurses, their roles incorporated reviews of referrals 
and test results, ordering additional tests and conducting 
clinical assessments. Following a minimum genetics train-
ing of 30 hours at Master’s level, they were competent to 
undertake family history collection and risk assessment, to 
triage patients and provide genetic and cardiac-related 
information and support, liaising with other specialist car-
diac nurses and genetic counsellors as appropriate. Initially, 
the ICC services were at varying stages of maturity and 
individual CGN roles were tailored according to the spe-
cific service needs of each site.
Stage 1: developing the Maturity Matrix
A Maturity Matrix (MM) is a two-dimensional instrument to 
evaluate organisational development over time (Figure1(a)), 
used widely in health service settings15 and primary care in 
Europe.16,17 The common underpinning concept of identify-
ing features of an organisation assessed over time partially 
dictates MM structure, but content varies and many are 
developed as new.18 It can be presented as a number of core 
concepts or domains, each with associated descriptors 
(individual components of a domain) comprising a series of 
indicators (describing items that can be measured) (Figure 
1(b)). Appropriate indicator measures are grouped into 
stages of maturity, creating a matrix of cells against an ordi-
nal scale (e.g. from ‘new’ to ‘established’). Progress is iden-
tified through self-assessment with a facilitator.
The development process is summarised within Figure 2. 
A consensus approach was adopted at a one-day meeting of 
multidisciplinary stakeholders from cardiology, genetics, 
education, charitable organisations and patient groups. Before 
the meeting, participants (selected for their expertise and/or 
role) were invited by email to nominate essential elements for 
an effective ICC service. Items generated were categorised 
into themes by one researcher, verified independently by a 
second, and overarching domains agreed. The meeting fol-
lowed a structured programme with a participative thematic 
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analytical approach whereby the stakeholders were involved 
in shaping the emerging framework by discussion throughout 
the day managed by an expert facilitator. Following review of 
the domains, participant groups considered three questions 
per domain in an iterative process (Figure 3). Electronic vot-
ing technology was used to agree the domains, outcome 
descriptors and indicators as a basis for further development. 
Participants were emailed for comments on the draft ICC-MM 
developed following the meeting. Further revision was made 
following consultation with the advisory group, ICC clinical 
leads at the host sites and the CGNs (Figure 2).
Stage 2: applying the MM
The ICC-MM was piloted at three sites, interviewing the 
CGNs for feedback on acceptability and the scope of meas-
ures appropriate as evidence for each indicator. The process 
was then discussed with all CGNs in a focus group (Figure 2). 
Refinements were made prior to the first self-assessments, 
which incorporated brief narratives from the CGNs against 
each matrix cell. Continuity was maintained by the same 
researcher visiting sites to clarify and audit evidence. Clinical 
leads at each site were asked to verify the completed report. 
Two interim ‘exception report’ self-assessments were con-
ducted in 2010, with a final full assessment in 2011. One 
CGN resigned in late 2010 and this site was subsequently 
excluded from further analysis.
Analysis
Self-assessments were coded and analysis was conducted 
blind. Two researchers independently analysed responses 
for each domain with disagreement resolved by discus-
sion. We assigned a number to the maturity stages of a 
six-point ordinal scale, ranging from ‘not yet emerging’ 
(=0) to ‘established’ (=5) for ease of locating sites on the 
ICC-MM. Each self-assessment was scored for each indi-
cator. Spider plots were produced for the baseline (2009) 
a. 
b. 
Domain A
Stage of maturity 
Outcome 
descriptor
Indicators Stage 1 Stage 2 Stage 3 Stage 4 etc.
Descriptor 
1
Indicator 1 Nothing of 
the 
measure is 
in place 
Something
of the 
measure is 
in place 
A little more 
of the 
measure is 
in place 
The measure 
is fully 
embedded in 
the service 
Indicator 2
Descriptor 
2
Indicator 1
Indicator 2
A
Domain descriptors 
  Indicators 
B
Domain descriptors 
  Indicators 
C
Domain descriptors 
  Indicators 
D
Domain descriptors 
  Indicators 
E
Domain descriptors 
  Indicators 
D
O
M
A
IN
S 
Maturity
Emerging 
Maturing
Established 
Figure 1. A Maturity Matrix. (a) Over time the organisation is able to identify performance that meets the expected measure for 
the appropriate stage of maturity (three stages shown for simplicity). (b) The working document is presented as a grid for self-
assessment.
Kirk et al. 421
and final (2011) assessments to visualise progress, using 
the mean scores for each indicator. The direction of 
change in scores over time was examined using the 
Wilcoxon signed-rank test, with descriptive statistics used 
to compare rate of change. A repeated measures ANOVA 
was performed to identify interaction effects between how 
long the ICC services had been established and changes 
observed over time.
Ethical considerations
The investigation conforms with the principles in the 
Declaration of Helsinki.19 Ethics approval was given by the 
University of Glamorgan Faculty Ethics Committee on 22 
February 2009. Offices overseeing governance at the host 
sites were notified of the evaluation programme.
Results
Stakeholders generated 37 items, categorised into five 
themes. Twenty-eight participants attended the meeting, 
including six CGNs. None disagreed with the descriptors 
and indicators developed, although strength of agreement 
varied and two people rated two domains neutral (Table 1). 
Fourteen subsequently commented on the draft ICC-MM 
and all advisory group members (n=14) contributed to fur-
ther refinement. The final ICC-MM outlined five domains 
accompanied by outcome descriptors, indicators (Table 2) 
and expected measures for stage of development (Table 1 in 
supplementary material online).
Comparison of means between 2009 and 2011 showed 
progress across the five domains (Figure 4), significant for 
all indicators bar four (supplemental Table 2). Spider plots 
based on the mean scores for indicators in each domain are 
presented in Figures 5–9.
Domain A: accessibility
Domain A is underpinned by documented, effective care 
pathways, multidisciplinary team (MDT) working and 
engagement of wider networks. By 2011 all sites reached 
the ‘Maturing’ stage as a minimum for all indicators (Figure 
5). ‘Effective utilisation of individualised care pathways’ 
(A1.2) was one of four indicators showing the highest rate 
Generation  by 
stakeholders of 
criteria to populate a 
maturity matrix (37 
items)
Thematic analysis by 
team of items 
generated 
March 2009: 
multidisciplinary
stakeholder meeting 
to draft maturity 
matrix
April–July: consultation
period/ advisory
group
Auguest–October: pilot
phase
Refinement and
production of maturity
matrix 
September–October:
consultation with
clinical leads
October:
pre-assessment
focus group with
CGNs
First self-assessment
reports and follow-up
interviews with CGNs
October 2009
Analysis of reports by
team
Further refinement of 
ICC-MM by team
Exception reports and
final self-assessment
October 2011
Final analysis of ICC-
MM reports by team
Figure 2. Stages of development and use of the ICC-Maturity Matrix (ICC-MM).
ICC: inherited cardiac condition
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of change (supplemental Table 2). Most CGNs cited triag-
ing and referral trends as evidence of effective use of care 
pathways:
Patients are triaged according to individual need by 
utilisation of pre-assessment telephone call. Inappropriate 
referrals can be intercepted…and the appropriate ‘at risk’ 
family members who need to be referred can be identified 
and a referral requested. High risk patients once identified 
are prioritised according to need and not waiting lists. 
(CGN-F, A1.2)
Commitment to audit and review of pathways was evident 
from the self-assessment narratives, such as CGN-G com-
menting ‘At present we are auditing 100 consecutive fami-
lies’. Progress in establishing effective working relationships 
was steady, with regular MDT meetings and network devel-
opment to include paediatric cardiologists, primary and sec-
ondary care colleagues and coroners. In the latter case:
These links result in speedier referrals of patients following a 
sudden death – hopefully reducing their anxiety levels. (CGN-
H, A3.1)
Group taska Group 1 Group 2 Group 3 Group 4
Round 1
• What does the established 
ICC service demonstrate? 
(Outcome descriptors)
• What will show this? 
(Indicators)
• What should we expect to see 
in emerging, maturing and 
established services? 
(Expected measure at stage)
Domain 
A and D
Domain 
B
Domain 
C
Domain 
E
Round 2
• Is there anything you would 
add/ remove/ amend
Domain 
E
Domain 
A and D
Domain 
B
Domain 
C
Round 3
• Is there anything you would 
add/ remove/ amend
• Etc. 
Domain 
C
Domain 
E
Domain 
A and D
Domain 
B
Final round
• Any further 
modifications?
Report back to whole group
Domain 
A and D
Domain 
B
Domain 
C
Domain 
E
Figure 3. The iterative review process to develop the ICC-MM.
aParticipants were allocated to multidisciplinary groups.
ICC-MM: inherited cardiac condition-Maturity Matrix
Table 1. Strength of agreement from participants (n=26) on domains, descriptors and indicators identified as a basis for MM 
development.
Domaina Strongly 
agree
Agree Somewhat 
agree
Neutral Somewhat 
disagree
Disagree Strongly 
disagree
A 5 17 4 0 0 0 0
B 2 15 7 2 0 0 0
C 6 15 4 1 0 0 0
E 5 11 10 0 0 0 0
aDue to time constraints, votes were not cast for Domain D.
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Formal establishment of wider interest groups (A3.2) 
was less widespread, but there were examples of good prac-
tice; one site (G) conducted a needs analysis with patients 
before establishing their pathway.
Domain B: communication and co-
ordination
Initially, most sites clustered around point 2 on the ordinal 
scale, ‘emerging/maturing’ in Domain B (Figure 6). By 
2011, services were ‘bedded down’; efficient running of 
clinics (B1.2) showed one of the highest levels of change 
(supplemental Table 2). CGN-F detailed the role of pre-
clinic telephone calls in preparation (B1.1):
A family history is taken and any other relevant informa-
tion collated;
Clinic slots are booked according to patient’s risk;
Patients are booked in to see the most appropriate 
member(s) of the MDT clinic;
A one-stop shop is coordinated.
Coordinating clinic appointments, whereby separate 
cardiology and genetics consultations and assessments 
could be conducted on the same day (‘one-stop shop’), was 
found important but not possible at all sites. One CGN 
explained that ‘unfortunately there doesn’t appear to be any 
scope (clinic space and time) for this within my clinical 
team’ (CGN-D, B1.1).
There was a clear focus on information provision, 
with CGNs using a variety of media before and at clin-
ics (B2.1). One site involved patient groups and the 
regional clinical governance team in reviewing leaflets 
prior to use. Gaps in literature provision were noted, 
such as ‘age appropriate literature for teenagers and 
children’ (CGN-E, B2.1). CGN-D established a patient 
support group, and six sites had conducted patient satis-
faction surveys.
Domain C: family centred
Most sites were initially assessed as emerging/maturing 
(point 2) against many indicators. There was clear commit-
ment to facilitating family-centred care (Figure 7). By 
2011, most sites were assessed as maturing (point 3) as a 
minimum. One site (G) reported how feedback from 
patients, families and the consultant geneticist indicated 
that patients were well informed about the service and their 
condition. There was evidence that patients’ and families’ 
views were actively sought and acted upon to try to accom-
modate their needs:
Families seen together whenever practical for them, even if it 
means overbooking for us. (CGN-B, C2.1)
Table 2. ICC-Maturity Matrix domains and descriptors.
Domain Outcome descriptors
A.  An accessible inherited cardiac conditions 
service, with a clearly articulated model of service 
provision 
A1. Integrated care pathways
A2.  Identify and facilitate key professionals to implement 
seamless care pathways
 A3. Clearly defined network at local and national levels
B.  A communicated and coordinated service, where 
the structure of the service is understood by all 
B1. Effective coordination of ICC service by CGN
B2. Effective communication of ICC service
C. Family-centred care C1. Empowered and supported to manage their own situation.
 C2. Patients feel they are treated as individuals
 C3.  Patients/families know who they should expect to see and 
what to expect from the service
 C4. Access to external services and support is clear
D. A sustainable and ethical service D1.  Plans are in place for a sustainable ICC service, supported 
by the host organisation
D2.  Host organisation invests to secure adequate and 
appropriate access to facilities and equipment
E.  Valuing the knowledge base, with a philosophy 
that embraces qualitative and quantitative 
evidence 
E1.  Delivering evidence-based services in line with national 
standards
E2. Monitoring evidence-base and keeping service updated
 E3. Education initiatives in place
 E4.  Collaborative engagement in ICC research programmes 
that value the patient voice
 E5.  Host organisation values the CGN role, providing effective 
continuing professional development, training, clinical 
supervision and resources
ICC: inherited cardiac condition; CGN: Cardiac Genetics Nurse
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Children’s needs were handled sensitively:
Plans can be made with parents prior to clinic as to how best 
to deal with children that are particularly traumatised by 
hospitals, especially if there has been a death in the family. 
(CGN-F, C2.1)
However, CGNs also used the self-assessment narrative to 
note concern around gaps in provision, including ‘a desper-
ate lack of bereavement support for children in our area’ 
(CGN-J, C2.3).
CGNs took steps to provide appropriate and up-to-date 
information about support groups with evidence of good 
follow-up practice. CGN-F commented that s/he will ‘often 
ask them if they accessed the support group and how it 
helped’.
Domain D: sustainable and ethical
In 2009, with one exception, sites were at the early stages 
of planning and implementing new services, or new devel-
opments within existing services. By 2011, all were actively 
pursuing, or had secured, future funding for the service 
(Figure 8, D1.1). There was some evidence of support from 
the host organisations in terms of governance frameworks 
and audit (D1.2) although this was not significantly 
changed:
Everyone helps wherever possible given the present limit of 
NHS resources. (CGN-B, D1.2).
A new indicator (D1.3) was introduced after the baseline 
assessment. Waiting times were generally well within 
national and local targets. Investment in the ICC service 
varied (D2.1), particularly in more recently established ser-
vices and change here was not significant. Clinic space was 
an issue at one site, and administrative support very limited 
at others. Two sites were especially constrained by resources 
for genetic testing. Even so, CGNs were positive about the 
impact of their role as an integral part of ICC services:
…with me in post this certainly improves the care trajectory 
for this patient group. (CGN-D, D2.1)
Domain E: continuous improvement
In the early stages, CGNs were not as involved in research, nor 
in educating professionals or the public (Figure 9). Only two 
sites were ‘maturing’ for these first two indicators and none for 
the latter. By 2011, effective monitoring arrangements had 
Not yet emerging/No 
comment
0
Emerging  1 
Emerging/maturing  2 
Maturing  3 
Maturing/established  4 
Established  5 
0
1
2
3
4
5
A Accessible 
service and 
pathways
B
Communicated
and 
coordinated
C Family 
centred
D Sustainable 
and ethical
E Evidence 
based
Baseline
average
2009
Final
average
2011
Figure 4. Mean scores across all sites for all domains 2009 and 2011.
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been developed with sound awareness of, and contribution 
towards, national guidelines although change was not signifi-
cant for E1.1. CGNs were involved in formal teaching ses-
sions across a range of audiences, within workload constraints. 
Sites were using the research evidence base and some CGNs 
were actively contributing through participation in multi-cen-
tre research studies and publishing in professional journals. 
Progress in patient/public participation in research (E4.2) was 
not significant.
CGNs were actively engaged in the BHF’s comprehen-
sive training programme and benefited from ‘in house’ 
mentoring and support:
…I have benefited tremendously by being mentored intensively 
by both the cardiology and genetics departments… [this] has 
helped patients get appropriate care and advice in a timely 
manner. (CGN-E, E5.2)
One of the fastest rates of change was in establishing clini-
cal and counselling supervision (E5.4).
Overall maturation
Comparing rate of progress of established sites (A, B, E and 
F) with the other sites (D, G, H and J) using mean total 
scores in 2009 and 2011 across all domains showed 
increased scores for both established and new/emerging 
sites, with a faster increase for newer services. The repeated 
measures ANOVA showed that, overall, increase from 
baseline to final score was significant (F=141.075, p<0.01); 
however, there was no significant interaction with the type 
of site (F=2.276, p=0.182).
Discussion
The ICC-MM developed for this study aimed to capture 
progress in service development following the CGN 
appointments to the nine ICC services. The framework 
incorporated the concepts of accessibility, communication 
and coordination of services, family-centred care, sustain-
ability and continuous improvement, for new through to 
Key to indicators 
A1.1  Collaborative development and documentation of standard care pathways 
A1.2  Effective utilisation of individualised care pathways 
A1.3  Regular process of review to update care pathways as appropriate 
A2.1  Effective working relationships 
A3.1 ICC Service stakeholders engaged 
A3.2 Interest group of patient pathway stakeholders 
0
1
2
3
4
5
A1.1 
A1.2 
A1.3 
A2.1 
A3.1
A3.2
Baseline 
assessment 2009
Final assessment 
2011
Not yet emerging/No comment  0 
Emerging  1 
Emerging/Maturing  2 
Maturing 3
Maturing/Established  4 
Established  5 
Figure 5. Domain A, an accessible inherited cardiac conditions service, with a clearly articulated model of service provision: mean 
scores across all sites for each indicator.
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established services. Without any existing benchmarks, the 
ICC-MM, developed with stakeholders, provided an indi-
cation of how services might be expected to progress as 
new initiatives became embedded in ICC service provision 
(supplemental Table 1). Significant progress was noted in 
all domains, for all bar four of the 37 indicators and at both 
established and new or emerging sites. Self-assessments 
Key to indicators 
B1.1  Effective preparation for clinics 
B1.2  Efficient running of clinics 
B1.3  Appropriate follow-up to clinics 
B2.1  Clear, accurate, relevant and timely information for general and specific purposes 
B2.2 Stakeholders aware of the service 
B2.3 Mechanisms in place to facilitate feedback and share information 
0
1
2
3
4
5
B1.1 
B1.2 
B1.3 
B2.1 
B2.2 
B2.3 
Baseline
assessment
2009
Final
assessment
2011
Figure 6. Domain B, a communicated and coordinated service, 
where the structure of the service is understood by all: mean 
scores across all sites for each indicator.
Key to indicators 
C1.1  Patients/families have appropriate knowledge and skills 
C1.2  Effective partnerships 
C2.1  Flexible approach to facilitate family centred care 
C2.2  Access to appropriate specialised services 
C2.3 Psychological, emotional and bereavement support as appropriate 
C3.1 Continuity of staff team 
C3.2 Coherent and informed message from the team 
C4.1 Information about support groups 
C4.2 Appropriate and timely referral to other services 
0
1
2
3
4
5
C1.1 
C1.2 
C2.1 
C2.2 
C2.3 C3.1 
C3.2 
C4.1 
C4.2 
Baseline 
assessment 2009
Final assessment 
2011
Figure 7. Domain C, family-centred care: mean scores across 
all sites for each indicator.
Key to indicators 
D1.1  Development of business case within appropriate defined timeframe 
D1.2  A workable governance system and process that exists to facilitate service development 
D1.3  Development of an ethical service that remains compliant with governance requirements 
D2.1  Access to services and infrastructure relevant to cardiology andgenetics 
0
1
2
3
4
5
D1.1 
D1.2 
D1.3 
D2.1 
Baseline 
assessment 2009
Final assessment 
2011
Figure 8. Domain D, a sustainable and ethical service: mean 
scores across all sites for each indicator.
0
1
2
3
4
5
E1.1
E1.2
E2.1
E3.1
E3.2
E4.1E4.2
E5.1 
E5.2
E5.3
E5.4
Baseline 
assessment 
2009
Final assessment 
2011
Key to indicators 
E1.1  Written guidelines 
E1.2  External quality assurance/assessment systems in place 
E2.1  Continuous cycle of audit and development across patient pathway 
E3.1  Involvement in public education 
E3.2 Involvement in professional education based on assessment/ review of learning needs 
E4.1  Recruitment for/involvement in research projects 
E4.2 Patients/public actively contribute to research 
E5.1 Evidence of annual performance review with regular performance development plan review 
E5.2  Comply with BHF education pathway/ other competence frameworks 
E5.3 Access to personal and professional support 
E5.4  Regular clinical and counselling supervision 
Figure 9. Domain E, valuing the knowledge base, with a 
philosophy that embraces qualitative and quantitative evidence: 
mean scores across all sites for each indicator.
BHF: British Heart Foundation
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demonstrated that CGNs have strategic insight into their 
service, identifying gaps in provision, offering solutions 
and achieving significant progress irrespective of the site’s 
initial stage of maturity.
Most progress was noted in Domains A–C and this is per-
haps to be expected in terms of the CGN’s potential to contrib-
ute to service development. Promoting an accessible service, 
underpinned by effective care pathways, multidisciplinary 
working and wider networks (Domain A) represents the cul-
mination of the initiative. The post is considered to be a timely 
addition to the multidisciplinary cardiac genetics team, includ-
ing at established sites.20 The CGN, in bridging genetics and 
cardiac services, is core to promoting ‘A communicated and 
coordinated service’ (Domain B). Family-centred care 
(Domain C), is a core nursing concept,21 empowering patients 
and families to share or make decisions and manage their con-
dition, with care planned around the family. The increasing 
importance of CGNs in providing support and psychosocial 
care has been noted.20,22 CGNs appeared committed to this 
concept and concerned about the constraints of both service 
arrangements and gaps in provision.
Progress in Domains D and E was more limited for some 
indicators, suggesting that initial efforts were focused on the 
clinical service. The non-significant changes in securing sus-
tainability and support (Domain D) with attendant uncer-
tainty on the continuation of employment post-BHF funding 
reflect the challenges of NHS commissioning during severe 
fiscal constraint. Even so, considerable effort was made to 
inform commissioners about the CGN posts. Domain E 
relates to continuous improvement, incorporating research 
and education. The importance of the CGN in education has 
been highlighted22 and progress against the ICC-MM indica-
tors related to this (E3.1, E3.2, E5.2) showed commitment to 
this role. Progress in relation to establishing written guide-
lines (E1.1) and patient involvement in research (E4.2) was 
not significant, again perhaps indicating that immediate ser-
vice demands were a greater priority.
Limitations of the case study approach centre largely on 
generalisability of findings. Circumstances surrounding this 
study were unusual, if not unique, with the appointment of 
nine CGNs to ICC services at different levels of maturity and 
some inconsistency of the specified roles of the CGNs. 
Reliance on self-assessment could have introduced bias, 
since revealing limited progress might have prejudiced fur-
ther funding. However, the researcher’s site visits, interview-
ing and reviewing evidence, counterbalanced this potential.
The sample was small, therefore results should be 
treated with caution and firm conclusions cannot be drawn. 
Furthermore, each CGN worked as part of a multidiscipli-
nary team and, although seen as catalysts for development, 
progress cannot be ascribed solely to their efforts. However, 
we believe the ICC-MM captured the general direction of 
service improvement and the accompanying narratives 
indicated the CGNs’ contribution to this.
Although CGN roles and ICC services were not identi-
cal, there were common features, including challenges, 
such as in raising awareness of the service and, paradoxi-
cally, coping with increasing demand. The application of 
the primary care MM across Europe assumes practices 
have common characteristics, develop along similar path-
ways and quality improvement processes are linear so lev-
els can be defined at stages along a pathway.23 We believe 
the ICC-MM developed in this study has relevance to ICC 
services in the UK and internationally. However, account 
must be taken of the context, with a rigorous approach to 
translation and training to ensure MM concepts are inter-
preted and applied consistently.16
We believe this is the first study to use a MM to evaluate 
ICC service development. Although the NHS National 
Service Framework outlined the services needed for families 
at risk of sudden cardiac death,14 detail to inform commis-
sioning was not available until 2010.24 The commissioning 
guide does not capture how ICC services might evolve 
although components show consistencies with ICC-MM 
domains and descriptors. We suggest that as well as marking 
progress, the ICC-MM provided a framework to inform ser-
vice development targets and could be of value to cardiac 
nurses in other centres nationally and internationally who are 
involved in developing ICC services, although the engage-
ment of the whole ICC team with this is important.
The integration of genetics and genomic technologies 
into medical specialisms like cardiology has been proposed 
as the future paradigm, with professionals developing 
expertise in the genetics aspects of the specialty and close 
relationships with genetics specialists an essential element 
of reconfigured services.13 In this context, the appointment 
of a cohort of CGNs to help develop ICC services provided 
an opportunity to explore their contribution to this evolving 
paradigm. The findings suggest that, after appropriate 
genetics training, cardiac nurses can apply their new knowl-
edge and skills successfully to help integrate care across the 
two specialisms, facilitating the development of effective 
and sustainable ICC services at new, developing, and more 
established ICC service locations. Having a firm grasp of 
genetics knowledge and skills applied to their specialist 
area will also provide these cardiac nurses with a founda-
tion on which to build as the new genomics paradigm grad-
ually unfolds.
Implications for practice
•	 Cardiac nurses gaining additional skills in genet-
ics can play a valuable role in integrating services 
across specialties.
•	 The ICC-MM may provide a useful framework for 
cardiac nurses involved in developing ICC 
services.
•	 Genetics is of relevance to cardiac nurses; rele-
vant knowledge and skills in this field provides a 
foundation for integration of genomics advances 
as they impact on healthcare.
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